These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11571511)

  • 1. High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis.
    Kumar S; Dispenzieri A; Lacy MQ; Litzow MR; Gertz MA
    Bone Marrow Transplant; 2001 Aug; 28(4):381-5. PubMed ID: 11571511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Wakui M; Okamoto S; Ishida A; Kobayashi H; Watanabe R; Yajima T; Iwao Y; Hisamatsu T; Hibi T; Ikeda Y
    Bone Marrow Transplant; 1999 Mar; 23(6):573-8. PubMed ID: 10217188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
    Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
    Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis.
    Oran B; Malek K; Sanchorawala V; Wright DG; Quillen K; Finn KT; La Valley M; Skinner M; Seldin DC
    Bone Marrow Transplant; 2005 Mar; 35(6):567-75. PubMed ID: 15665842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experience.
    Chow LQ; Bahlis N; Russell J; Chaudhry A; Morris D; Brown C; Stewart DA
    Bone Marrow Transplant; 2005 Oct; 36(7):591-6. PubMed ID: 16062177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis.
    Fernández de Larrea C; Cibeira MT; Rovira M; Rosiñol L; Esteve J; Bladé J
    Eur J Haematol; 2008 Feb; 80(2):182-4. PubMed ID: 18081703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL).
    Gertz MA; Lacy MQ; Gastineau DA; Inwards DJ; Chen MG; Tefferi A; Kyle RA; Litzow MR
    Bone Marrow Transplant; 2000 Nov; 26(9):963-9. PubMed ID: 11100275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987-1997: incidence, causes, and outcome.
    Schwartz JM; Wolford JL; Thornquist MD; Hockenbery DM; Murakami CS; Drennan F; Hinds M; Strasser SI; Lopez-Cubero SO; Brar HS; Ko CW; Saunders MD; Okolo CN; McDonald GB
    Am J Gastroenterol; 2001 Feb; 96(2):385-93. PubMed ID: 11232680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infections during mobilizing chemotherapy and following autologous stem cell transplantation.
    Toor AA; van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2001 Dec; 28(12):1129-34. PubMed ID: 11803354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High risk factors of upper gastrointestinal bleeding after neurosurgical procedures].
    Zheng K; Wu G; Cheng NN; Yao CJ; Zhou LF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(48):3387-91. PubMed ID: 16409857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome.
    Mollee PN; Wechalekar AD; Pereira DL; Franke N; Reece D; Chen C; Stewart AK
    Bone Marrow Transplant; 2004 Feb; 33(3):271-7. PubMed ID: 14647248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis.
    Schulenburg A; Kalhs P; Oberhuber G; Reiter E; Base W; Greinix HT
    Bone Marrow Transplant; 1998 Aug; 22(3):293-5. PubMed ID: 9720746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL).
    Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar SK; Leung N; Gastineau DA
    Bone Marrow Transplant; 2007 Nov; 40(10):989-93. PubMed ID: 17846598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
    Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA
    Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis.
    Irazabal MV; Eirin A; Gertz MA; Dispenzieri A; Kumar S; Buadi FK; Lacy MQ; Hayman SR; Dingli D; Hogan WJ; Gastineau DA; Glavey SV; Amer H; Leung N
    Am J Hematol; 2012 Jan; 87(1):51-4. PubMed ID: 22076913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice.
    Lanas A; García-Rodríguez LA; Polo-Tomás M; Ponce M; Alonso-Abreu I; Perez-Aisa MA; Perez-Gisbert J; Bujanda L; Castro M; Muñoz M; Rodrigo L; Calvet X; Del-Pino D; Garcia S
    Am J Gastroenterol; 2009 Jul; 104(7):1633-41. PubMed ID: 19574968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autologous stem cell transplantation in the treatment of primary systemic amyloidosis].
    Gil L; Komarnicki M
    Pol Merkur Lekarski; 2009 Sep; 27(159):181-4. PubMed ID: 19827724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.